Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

 

→ About Us

 

→ Our papers

 

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
Welcome to the 19th issue of the AMYPAD newsletter
Welcome to the 19th issue of the AMYPAD newsletter 19 Nov 2021 We have now entered the final (6th) year of AMYPAD, and I hope you enjoyed the general assembly meeting in early October like I did......
AMYPAD presents at CTAD21
AMYPAD presents at CTAD21 15 Nov 2021 Two AMYPAD members had the opportunity to travel and spend few days in Boston to discuss science and interact with delegates......
Congratulations to Marthe and Fiona for their PhD thesis
Congratulations to Marthe and Fiona for their PhD thesis 11 Nov 2021 We would like to congratulate Marthe Smedinga and Fiona Heeman on successfully defending their PhD thesis......
Recruitment status (as 29 October, 2021)
Recruitment status (as 29 October, 2021)